Eton Pharma falls as US FDA declines to approve methanol poisoning treatment

Eton Pharmaceuticals

28/06/2023 12:26

** Shares of drugmaker Eton Pharmaceuticals Inc  ETON.O 
fall 15.84% to $3.4 premarket
    ** Co says U.S. FDA declined to approve its dehydrated
alcohol injection for the treatment of methanol poisoning
    ** The issues cited by the FDA in the complete response
letter relate primarily to chemistry manufacturing and controls
- ETON
     ** Co says all issues are addressable and will develop a
comprehensive action plan to address the FDA's concerns
    ** Up to last close, stock up ~43% YTD

 (Reporting by Sriparna Roy in Bengaluru)
 ((Sriparna.Roy@thomsonreuters.com;))